The objective of this clinical investigation is to assess the safety and performance of the SonoClear Acoustic Coupling Fluid (ACF). The performance will be assessed by analysis of the contrast-to-noise ratio (CNR) and assessment of image quality by using the Surgeon Image Rating (SIR) Scale. This is a prospective, multi-centre single-arm study where the performance of SonoClear ACF relative to routinely used acoustic coupling fluid is investigated by each patient being their own control. Patients with the diagnosis of HGG and LGG at up to 10 sites will be included. Additionally, safety data are collected at 30 days and 6 months post-procedure.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Contrast-to-Noise Ratio (CNR) to quantify the reduction in noise
Timeframe: During ultrasound guided brain tumour resection
Surgeons Image Rating (SIR) to assess the image quality
Timeframe: During ultrasound guided brain tumour resection
Adverse events up to 30 days post procedure
Timeframe: safety data are collected up to 30 days post procedure